74 research outputs found
Batch and continuous removal of heavy metals from industrial effluents using microbial consortia
Bio-removal of heavy metals, using microbial biomass, increasingly attracting scientific attention due to their significant role in purification of different types of wastewaters making it reusable. Heavy metals were reported to have a significant hazardous effect on human health, and while the conventional methods of removal were found to be insufficient; microbial biosorption was found to be the most suitable alternative. In this work, an immobilized microbial consortium was generated using Statistical Design of Experiment (DOE) as a robust method to screen the efficiency of the microbial isolates in heavy metal removal process. This is the first report of applying Statistical DOE to screen the efficacy of microbial isolates to remove heavy metals instead of screening normal variables. A mixture of bacterial biomass and fungal spores was used both in batch and continuous modes to remove Chromium and Iron ions from industrial effluents. Bakery yeast was applied as a positive control, and all the obtained biosorbent isolates showed more significant efficiency in heavy metal removal. In batch mode, the immobilized biomass was enclosed in a hanged tea bag-like cellulose membrane to facilitate the separation of the biosorbent from the treated solutions, which is one of the main challenges in applying microbial biosorption at large scale. The continuous flow removal was performed using fixed bed mini-bioreactor, and the process was optimized in terms of pH (6) and flow rates (1 ml/min) using Response Surface Methodology. The most potential biosorbent microbes were identified and characterized. The generated microbial consortia and process succeeded in the total removal of Chromium ions and more than half of Iron ions both from standard solutions and industrial effluents
Recommended from our members
An assessment of the impact of herb-drug combinations used by cancer patients
Background
Herb/Dietary Supplements (HDS) are the most popular Complementary and Alternative Medicine (CAM) modality used by cancer patients and the only type which involves the ingestion of substances which may interfere with the efficacy and safety of conventional medicines. This study aimed to assess the level of use of HDS in cancer patients undergoing treatment in the UK, and their perceptions of their effects, using 127 case histories of patients who were taking HDS. Previous studies have evaluated the risks of interactions between HDS and conventional drugs on the basis on numbers of patient using HDSs, so our study aimed to further this exploration by examining the actual drug combinations taken by individual patients and their potential safety.
Method
Three hundred seventy-five cancer patients attending oncology departments and centres of palliative care at the Oxford University Hospitals Trust (OUH), Duchess of Kent House, Sobell House, and Nettlebed Hospice participated in a self-administered questionnaire survey about their HDS use with their prescribed medicines. The classification system of Stockley’s Herbal Medicine’s Interactions was adopted to assess the potential risk of herb-drug interactions for these patients.
Results
127/375 (34 %; 95 % CI 29, 39) consumed HDS, amounting to 101 different products. Most combinations were assessed as ‘no interaction’, 22 combinations were categorised as ‘doubt about outcomes of use’, 6 combinations as ‘Potentially hazardous outcome’, one combination as an interaction with ‘Significant hazard’, and one combination as an interaction of “Life-threatening outcome”. Most patients did not report any adverse events.
Conclusion
Most of the patients sampled were not exposed to any significant risk of harm from interactions with conventional medicines, but it is not possible as yet to conclude that risks in general are over-estimated. The incidence of HDS use was also less than anticipated, and significantly less than reported in other areas, illustrating the problems when extrapolating results from one region (the UK), in one setting (NHS oncology) in where patterns of supplement use may be very different to those elsewhere
Rhaponticum acaule (L) DC essential oil: chemical composition, in vitro antioxidant and enzyme inhibition properties
Background: α-glucosidase is a therapeutic target for diabetes mellitus (DM) and α-glucosidase inhibitors play a
vital role in the treatments for the disease. Furthermore, xanthine oxidase (XO) is a key enzyme that catalyzes
hypoxanthine and xanthine to uric acid which at high levels can lead to hyperuricemia which is an important cause
of gout. Pancreatic lipase (PL) secreted into the duodenum plays a key role in the digestion and absorption of fats.
For its importance in lipid digestion, PL represents an attractive target for obesity prevention.
Methods: The flowers essential oil of Rhaponticum acaule (L) DC (R. acaule) was characterized using gas
chromatography-mass spectrometry (GC-MS). The antioxidant activities of R. acaule essential oil (RaEO) were also
determined using 2,2’-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), reducing power,
phosphomolybdenum, and DNA nicking assays. The inhibitory power of RaEO against α-glucosidase, xanthine
oxidase and pancreatic lipase was evaluated. Enzyme kinetic studies using Michaelis-Menten and the derived
Lineweaver-Burk (LB) plots were performed to understand the possible mechanism of inhibition exercised by the
components of this essential oil.
Results: The result revealed the presence of 26 compounds (97.4%). The main constituents include germacrene D
(49.2%), methyl eugenol (8.3%), (E)-β-ionone (6.2%), β-caryophyllene (5.7%), (E,E)-α-farnesene (4.2%),
bicyclogermacrene (4.1%) and (Z)-α-bisabolene (3.7%). The kinetic inhibition study showed that the essential oil
demonstrated a strong α-glucosidase inhibiton and it was a mixed inhibitor. On the other hand, our results
evidenced that this oil exhibited important xanthine oxidase inhibitory effect, behaving as a non-competitive
inhibitor. The essential oil inhibited the turkey pancreatic lipase, with maximum inhibition of 80% achieved at
2 mg/mL. Furthermore, the inhibition of turkey pancreatic lipase by RaEO was an irreversible one.
Conclusion: The results revealed that the RaEO is a new promising potential source of antioxidant compounds,
endowed with good practical applications for human health.
Keywords: α-glucosidase, Antioxidant activity, Chemical composition, Pancreatic lipase inhibition, Rhaponticum
acaule essential oil, Xanthine oxidase
Empty Forest Syndrome: Are we there yet? A preliminary Analysis of the Hunting and Poaching Activities in Selected Areas in Sabah, Malaysia
Hunting poses a longstanding threat to tropical wildlife conservation, now reaching critical levels. In Borneo, Malaysia, around six million animals were hunted yearly in the 1990s, about 36 per sq. km. High demand for game meat, facilitated by improved transportation, drives unsustainable consumption across the tropics. Depletion of animal populations leads hunters to new areas. Roughly 18% of rainforests are protected, yet pressures persist, endangering species due to weak regulations, limited resources, and external threats. This study examines wildlife hunting trends in Sabah, uncovering insights from community interviews regarding hunting impact and resource dependence. A total of 45 people were interviewed in six study areas: Sandakan, Tawau, Kota Belud, Tambunan, Keningau and Tenom. It was found that local communities hunt for food and that hunting is a common way of life for them. Based on the arrests of hunters by the Wildlife Rescue Unit, a report on animal hunting was compiled by the Sabah Wildlife Department and analysed. The most commonly hunted animal is the bearded pig. Parts of bearded pigs were found in the cars of 76.97% of hunters arrested, followed by parts of sambar deer (13.7%). Throughout Sabah, the empty forest syndrome (EFS) is becoming a dangerous silent disaster. While most "simple" forest features are attractive to the eye, they are gradually losing their ecological function. Although this study is not exhaustive, the preliminary findings point to a serious EFS scenario in Sabah if everyone continues to neglect the syndrome and do nothing about it
Bio-inspired computation: where we stand and what's next
In recent years, the research community has witnessed an explosion of literature dealing with the adaptation of behavioral patterns and social phenomena observed in nature towards efficiently solving complex computational tasks. This trend has been especially dramatic in what relates to optimization problems, mainly due to the unprecedented complexity of problem instances, arising from a diverse spectrum of domains such as transportation, logistics, energy, climate, social networks, health and industry 4.0, among many others. Notwithstanding this upsurge of activity, research in this vibrant topic should be steered towards certain areas that, despite their eventual value and impact on the field of bio-inspired computation, still remain insufficiently explored to date. The main purpose of this paper is to outline the state of the art and to identify open challenges concerning the most relevant areas within bio-inspired optimization. An analysis and discussion are also carried out over the general trajectory followed in recent years by the community working in this field, thereby highlighting the need for reaching a consensus and joining forces towards achieving valuable insights into the understanding of this family of optimization techniques
Fluoride concentrations in the pineal gland, brain and bone of goosander (Mergus merganser) and its prey in Odra River estuary in Poland
The global retinoblastoma outcome study : a prospective, cluster-based analysis of 4064 patients from 149 countries
DATA SHARING : The study data will become available online once all analyses are complete.BACKGROUND : Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed on a global scale. We aimed to report 3-year outcomes for children with retinoblastoma globally and to investigate factors associated with survival. METHODS : We did a prospective cluster-based analysis of treatment-naive patients with retinoblastoma who were diagnosed between Jan 1, 2017, and Dec 31, 2017, then treated and followed up for 3 years. Patients were recruited from 260 specialised treatment centres worldwide. Data were obtained from participating centres on primary and additional treatments, duration of follow-up, metastasis, eye globe salvage, and survival outcome. We analysed time to death and time to enucleation with Cox regression models. FINDINGS : The cohort included 4064 children from 149 countries. The median age at diagnosis was 23·2 months (IQR 11·0–36·5). Extraocular tumour spread (cT4 of the cTNMH classification) at diagnosis was reported in five (0·8%) of 636 children from high-income countries, 55 (5·4%) of 1027 children from upper-middle-income countries, 342 (19·7%) of 1738 children from lower-middle-income countries, and 196 (42·9%) of 457 children from low-income countries. Enucleation surgery was available for all children and intravenous chemotherapy was available for 4014 (98·8%) of 4064 children. The 3-year survival rate was 99·5% (95% CI 98·8–100·0) for children from high-income countries, 91·2% (89·5–93·0) for children from upper-middle-income countries, 80·3% (78·3–82·3) for children from lower-middle-income countries, and 57·3% (52·1-63·0) for children from low-income countries. On analysis, independent factors for worse survival were residence in low-income countries compared to high-income countries (hazard ratio 16·67; 95% CI 4·76–50·00), cT4 advanced tumour compared to cT1 (8·98; 4·44–18·18), and older age at diagnosis in children up to 3 years (1·38 per year; 1·23–1·56). For children aged 3–7 years, the mortality risk decreased slightly (p=0·0104 for the change in slope). INTERPRETATION : This study, estimated to include approximately half of all new retinoblastoma cases worldwide in 2017, shows profound inequity in survival of children depending on the national income level of their country of residence. In high-income countries, death from retinoblastoma is rare, whereas in low-income countries estimated 3-year survival is just over 50%. Although essential treatments are available in nearly all countries, early diagnosis and treatment in low-income countries are key to improving survival outcomes.The Queen Elizabeth Diamond Jubilee Trust and the Wellcome Trust.https://www.thelancet.com/journals/langlo/homeam2023Paediatrics and Child Healt
Evaluation of the acute antihyperglycemic effects of four selected indigenous plants from Jordan used in traditional medicine
Shake Table Testing: A High-Resolution Vertical Accelerometer Array for Tracking Shear Wave Velocity
- …